Company profile
Avant Brands Inc.
OTC: AVTBF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Kelowna, BCReports USD
#523 of 1,418 Healthcare companies by revenue37th-percentile growth
EA Score
59CFH 61DQ —GM 55SS 52
v0.1 · 45/100 weight · provisional
↑ Piotroski F, workforce scale · ↓ revenue growth (YoY), listing tenure
Methodology →Revenue TTM
$30.0M
Rev growth YoY (TTM)
+14.6%
Net income (FY)
-$7.0M
Employees
180
as of 2026-08-23
Market cap
$7.4M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$25.6M35.9M CAD2025
Net income-$7.0M-9.9M CAD2025
Operating income-$10.2M-14.4M CAD2025
Total assets$35.2M49.2M CAD2025
Liabilities$17.5M24.4M CAD2025
Equity$17.7M24.8M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Avant Brands Inc.’s revenue?
Avant Brands Inc. booked $25.6M in FY2025 revenue, contracting 2.6% year over year — slower than 63% of Healthcare companies we track, at a -27.5% net margin.
Peers · Healthcare
Synovics Pharmaceuticals, Inc.——Biocept, Inc.——Gelesis Holdings, Inc.——Entrada Therapeutics, Inc.46DMetagenomi, Inc. Common Stock40DIonic Brands Corp.——Key facts
CEONorton Singhavon
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersKelowna, BC
ExchangeOTC: AVTBF
Employees180
IPO date2018-07-10
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.